Metraipolis › archive › dc_b6704cd22e90
Immunocytokines in cancer immunotherapy: opportunities and challenges — Europe PMC PMID:41568361
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41568361
- DOI
- 10.3389/fonc.2025.1716612
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T00:58:00.352Z
- SHA-256 of the archived text
4f49407f1836d33388be52cd050a91d84cf107ae3e7f86946d3a2646a8c583be- Stable URL of this page
https://metraipolis.com/documento/dc_b6704cd22e90
How to cite
Immunocytokines in cancer immunotherapy: opportunities and challenges — Europe PMC PMID:41568361 — Europe PMC (en), https://europepmc.org/article/MED/41568361 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b6704cd22e90 (Metraipolis archive dc_b6704cd22e90, sha256 4f49407f1836d33388be52cd050a91d84cf107ae3e7f86946d3a2646a8c583be)
BibTeX
@misc{dcb6704cd22e90,
title = {Immunocytokines in cancer immunotherapy: opportunities and challenges — Europe PMC PMID:41568361},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41568361},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b6704cd22e90; sha256 4f49407f1836d33388be52cd050a91d84cf107ae3e7f86946d3a2646a8c583be},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41568361. Agents can read the archived copy with the MCP tool read_document.